Are Biliary Tract and Gallbladder Carcinomas Treatable with Irinotecan?

Publisher： Karger

E-ISSN： 2296-5262|23|4|29-30

ISSN： 2296-5270

Source： Oncology Research and Treatment, Vol.23, Iss.4, 2000-05, pp. : 29-30

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Phase II Study with Gemcitabine in Gallbladder and Biliary Tract Carcinomasa

By  

Oncology Research and Treatment, Vol. 21, Iss. 3, 1998-07 ,pp. : 232-234

Karger

Access to resources Recommend Favorite

Clinical and pathological features of intraductal papillary neoplasm of the biliary tract and gallbladder

By  

HPB, Vol. 17, Iss. 9, 2015-09 ,pp. : 811-818

John Wiley & Sons Inc

Access to resources Recommend Favorite

Trypsinogen-1, -2 and tumour-associated trypsin-inhibitor in bile and biliary tract tissues from patients with biliary tract diseases and pancreatic carcinomas

By Hedström J.   Haglund C.   Leinonen J.   Nordling S.   Stenman U.-H.  

Scandinavian Journal of Clinical and Laboratory Investigation, Vol. 61, Iss. 2, 2001-04 ,pp. : 111-118

Informa Healthcare

Access to resources Recommend Favorite

A Multicenter Phase II Trial with Irinotecan plus Oxaliplatin as First-Line Treatment for Inoperable/Metastatic Cancer of the Biliary Tract

By  

Oncology, Vol. 78, Iss. 5-6, 2010-08 ,pp. : 356-360

Karger

Access to resources Recommend Favorite

Gemcitabine for the Treatment of Advanced Biliary Tract Carcinomas: Evaluation of Two Different Dose Regimens

By  

Oncology Research and Treatment, Vol. 22, Iss. 6, 2000-01 ,pp. : 498-501

Karger

Access to resources Recommend Favorite